In 2019, the global antimicrobial additives market attained a valuation of $2,010.2 million. According to the forecast of the market research company, P&S Intelligence, the market would exhibit a CAGR of 7.5% between 2020 and 2030 and reach a value of $3,786.8 million by 2030. Several technological and economic factors such as the boom of the healthcare industry and the incorporation of advanced technologies in healthcare product manufacturing are fueling the growth of the market.


Besides the aforementioned factors, the rising bio-resistance in patients, because of the excessive usage of antibiotic medicines, is also propelling the expansion of the antimicrobial additives market. The extensive administration of antibiotics in people for treating and reducing the risk of bacterial and fungal infections has massively contributed to the emergence of highly-resistant and stronger pathogens. Furthermore, the usage of disinfection chemicals augments the problem as these chemicals do not provide long-lasting protection and cause irregular activity.

Get the sample copy of the market analysis at: https://www.psmarketresearch.com/market-analysis/antimicrobial-additives-market/report-sample

Additionally, the large-scale adoption of inorganic antimicrobial additives in packaging products and food and non-food consumer items contributed to the rapid expansion of this category in the market in the past. When end-use industry is taken into consideration, the antimicrobial additives market is categorized into healthcare, automotive, food & beverages, packaging, consumer goods, and construction. Out of these, the healthcare category recorded the highest growth in the market in the last few years.

The category is also predicted to register a considerably high growth in the market in the upcoming years, primarily because of the rising incidence of hospital-associated infections (HAIs) and nosocomial infections across the world. Globally, the antimicrobial additives market is predicted to demonstrate lucrative growth in Asia-Pacific (APAC) in the forthcoming years, on account of the rapid economic growth of the regional countries and the increasing spending power of the people in these countries.


Thus, it is clear that due to the rising incidence of chronic diseases, the increasing resistance of pathogens to conventionally used drugs, and the rapid technological advancements in the pharmaceuticals industry, the market would grow explosively all over the world in the coming years.